Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

This grant supports activities enabling equal access to innovative, sustainable, and high-quality healthcare by reducing adverse drug reactions (ADRs) stemming from the administration of multiple medications (three or more). The objective is to improve patient safety, outcomes, and cost savings through prevention strategies, integration of genetic and biomarker information, and technological innovation in medication management. Results are expected to benefit patients, healthcare professionals, and healthcare systems by decreasing ADRs, guiding clinical and regulatory guidelines, and raising awareness through educational programs.

AgencyHORIZON (EU)
RegionEU
CountryN/A
Legal formCompany, NGO, Government organization, House union, Private person, Other
Start date10 Feb 2027
End date13 Apr 2027
Max funding8,000,000 to 10,000,000 EUR per project
Budget38,000,000 EUR (2027)
Coverage

Projects are expected to provide co-funding as per Horizon Europe rules; typical coverage up to 100% for Research and Innovation Actions, subject to eligibility and cost type.

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications • EUGrants.AI